Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (7139)	10/11/1999 12:14:00 AM
From: rkrw	Read Replies (1) \| Respond to of 9719

<<Cyto sell INHL at the open. Buy 1000 GLIA at 11 or better>> Any company specific reason for selling INHL? INHL has been a little bit weak on the heels of their convertible offering but did get a couple of strong buy reiterations in the aftermath. Re: GLIA. I've done very well in a few FDA mfg issue depressed stocks. Barr Labs, Bolar and KV Pharmaceutical to name a few. I would warn that oftentimes these things have a way of lasting much longer than would appear rational.